My CMT Story

…the lack of answers. Read More Dr. Katherine Forsey and her 7 year-old son, Samson Dr Katherine Forsey, the CMTA’s new Chief Research Officer, shares her story of a recent…

Gilles Bouchard Takes Helm of CMTA Board

…that while he is “excited and delighted” with the progress made by the CMTA’s STAR research program, there’s still much work to be done before a first drug treatment for…

Corporate Partners

…a significant portion back to support ongoing research and advocacy. Join us in planting seeds of health and harvesting a future of hope! “To feel my best, it all starts…

New CEO Takes Helm of the CMTA

…be to aggressively pursue potential treatments, and ultimately a cure for CMT, with the Strategy to Accelerate Research (STAR). I firmly believe the CMTA is on the brink of advancing…

2014_Stanford_PFC_Agenda

…ongoing research defining causes, diagnosis and novel treatments of genetic neuromuscular disorders. Prior to his arrival at Stanford in 2011, Dr. Day directed the Paul and Sheila Wellstone Muscular Dystrophy…

CMTA_2014-2015_Audited_Financial_Statements

…224,324 2015 2014 Revenues 6,054 5,746 Expenses 7,404 7,544 Net (1,350) (1,798) 5. Research Grants Payable Research Grants Payable reflects amounts earmarked for research payment, but which haven’t yet been…

CMTA_2010_Form_990

Research fellowships & grants for research on CMT Disease. Published quarterly newsletter & other publications for patients, their families, and medical practitioners to assist in understanding & treating Charcot-Marie-Tooth Disease….

TMJulia_22

CMTAUSA.ORG The Driving Force Behind CMT Research. ACCELERATING RESEARCH. EMPOWERING PATIENTS. P.O. Box 105 Glenolden, PA 19036 800-606-2682 CMTA LETTERHEAD_Final.indd 1 4/4/19 11:14 AM Team Julia ’22 — Raising Funds…

TMJulia_22

CMTAUSA.ORG The Driving Force Behind CMT Research. ACCELERATING RESEARCH. EMPOWERING PATIENTS. P.O. Box 105 Glenolden, PA 19036 800-606-2682 CMTA LETTERHEAD_Final.indd 1 4/4/19 11:14 AM Team Julia ’22 — Raising Funds…